Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × pyrotinib × Clear all

NCT03772353 2023-03-07

PLEASURABLE

Phase 1/2 Unknown

Breast Neoplasms

NCT04582968 2023-01-18

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Phase 1/2 Unknown

Brain Neoplasms, Breast Neoplasms